Victor Aboyans Selected Research

Peripheral Vascular Diseases (Peripheral Vascular Disease)

10/2021	Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
1/2021	Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS).
1/2021	Clinical cases referring to current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS).
1/2020	Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
12/2019	Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
11/2019	Editor's Choice - Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
11/2018	Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Aboyans Research Topics

Disease

32	Peripheral Arterial Disease 12/2022 - 09/2005
21	Stroke (Strokes) 12/2022 - 04/2005
15	Hemorrhage 12/2022 - 05/2013
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 01/2017
8	Myocardial Infarction 12/2022 - 06/2008
8	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 02/2007
7	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2021 - 11/2018
4	Neoplasms (Cancer) 01/2021 - 12/2012
4	Ischemic Stroke 01/2021 - 01/2018
4	Renal Insufficiency (Renal Failure) 01/2021 - 06/2008
4	Hypertension (High Blood Pressure) 01/2019 - 04/2007
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 03/2005
3	Atherosclerosis 01/2020 - 01/2016
2	Intermittent Claudication 02/2022 - 01/2018
2	Chronic Limb-Threatening Ischemia 02/2022 - 01/2019
2	Heart Failure 01/2022 - 01/2021
2	Amyloidosis 01/2022 - 01/2018
2	Thrombosis (Thrombus) 10/2021 - 01/2018
2	Aortic Diseases 01/2021 - 01/2021
2	Aortic Dissection 11/2020 - 11/2018
2	Carotid Stenosis (Carotid Artery Stenosis) 11/2020 - 01/2018
2	Pathologic Constriction (Stenosis) 11/2020 - 01/2016
2	Carotid Artery Diseases 04/2019 - 01/2018
2	Ischemia 01/2019 - 01/2018
2	Obesity 01/2019 - 01/2018
2	Cardiotoxicity 01/2019 - 01/2017
2	Embolism (Embolus) 11/2018 - 06/2005
2	Chronic Renal Insufficiency 10/2013 - 09/2007
2	Transient Ischemic Attack 10/2010 - 06/2008
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2006 - 04/2005
1	Thromboembolism 01/2021
1	Disease Progression 01/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Fibromuscular Dysplasia 01/2021
1	Cerebral Infarction 11/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020
1	Atrial Fibrillation 03/2019
1	Hypercholesterolemia 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Diabetes Mellitus 01/2019
1	Infections 01/2019
1	False Aneurysm (Pseudoaneurysm) 11/2018
1	Calcinosis 11/2018
1	Arteritis 11/2018
1	Overweight 01/2018
1	Cardiomyopathies (Cardiomyopathy) 09/2016
1	Heart Diseases (Heart Disease) 09/2016
1	Growth Disorders 12/2015
1	Malnutrition (Nutritional Deficiencies) 12/2015
1	Aortic Valve Stenosis (Aortic Stenosis) 09/2014
1	Dementia (Dementias) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014

Drug/Important Bio-Agent (IBA)

13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 01/2017
11	RivaroxabanIBA 12/2022 - 01/2017
7	AnticoagulantsIBA 01/2022 - 01/2018
3	LipidsIBA 01/2021 - 06/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020 - 08/2006
3	CholesterolIBA 01/2020 - 09/2010
2	Vitamin K FDA Link 01/2022 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2018
2	Complement System Proteins (Complement)IBA 11/2020 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 10/2007
2	Clopidogrel (Plavix)FDA Link 04/2019 - 07/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 09/2016
2	HDL CholesterolIBA 11/2017 - 04/2007
2	CalciumIBA 01/2016 - 02/2007
2	Antihypertensive Agents (Antihypertensives)IBA 10/2007 - 03/2005
1	TroponinIBA 02/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	IronIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Proton Pump InhibitorsIBA 01/2017
1	SaltsIBA 01/2017
1	PotassiumIBA 01/2017
1	AnthracyclinesIBA 01/2017
1	Trichloroethylene (Trichloroethene)IBA 12/2015
1	SmokeIBA 12/2015
1	Insulin (Novolin)FDA Link 01/2014

Therapy/Procedure

18	Therapeutics 10/2021 - 06/2005
12	Vascular Surgical Procedures 12/2019 - 06/2008
7	Surgical Amputation (Amputations) 01/2021 - 10/2013
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2019 - 04/2005
3	Secondary Prevention 12/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
2	Endovascular Aneurysm Repair 01/2021 - 01/2021
2	Radiotherapy 11/2020 - 01/2019
2	Stents 11/2018 - 01/2018
1	Polypharmacy 11/2022
1	Carotid Endarterectomy 11/2020
1	Aftercare (After-Treatment) 01/2019
1	Prostheses and Implants (Prosthesis) 09/2014